INMB
Price
$7.63
Change
+$0.36 (+4.95%)
Updated
Jun 4 closing price
Capitalization
177.1M
55 days until earnings call
WINT
Price
$0.67
Change
-$0.12 (-15.19%)
Updated
Jun 4 closing price
Capitalization
2.44M
Interact to see
Advertisement

INMB vs WINT

Header iconINMB vs WINT Comparison
Open Charts INMB vs WINTBanner chart's image
INmune Bio
Price$7.63
Change+$0.36 (+4.95%)
Volume$751.01K
Capitalization177.1M
Windtree Therapeutics
Price$0.67
Change-$0.12 (-15.19%)
Volume$611.62K
Capitalization2.44M
INMB vs WINT Comparison Chart
Loading...
INMB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WINT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INMB vs. WINT commentary
Jun 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INMB is a Hold and WINT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 05, 2025
Stock price -- (INMB: $7.63 vs. WINT: $0.67)
Brand notoriety: INMB and WINT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INMB: 280% vs. WINT: 188%
Market capitalization -- INMB: $177.1M vs. WINT: $2.44M
INMB [@Biotechnology] is valued at $177.1M. WINT’s [@Biotechnology] market capitalization is $2.44M. The market cap for tickers in the [@Biotechnology] industry ranges from $318.09B to $0. The average market capitalization across the [@Biotechnology] industry is $2.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INMB’s FA Score shows that 0 FA rating(s) are green whileWINT’s FA Score has 1 green FA rating(s).

  • INMB’s FA Score: 0 green, 5 red.
  • WINT’s FA Score: 1 green, 4 red.
According to our system of comparison, WINT is a better buy in the long-term than INMB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INMB’s TA Score shows that 2 TA indicator(s) are bullish while WINT’s TA Score has 5 bullish TA indicator(s).

  • INMB’s TA Score: 2 bullish, 5 bearish.
  • WINT’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, WINT is a better buy in the short-term than INMB.

Price Growth

INMB (@Biotechnology) experienced а -0.26% price change this week, while WINT (@Biotechnology) price change was -20.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.56%. For the same industry, the average monthly price growth was +5.22%, and the average quarterly price growth was -1.09%.

Reported Earning Dates

INMB is expected to report earnings on Jul 30, 2025.

WINT is expected to report earnings on Apr 15, 2025.

Industries' Descriptions

@Biotechnology (+6.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INMB($177M) has a higher market cap than WINT($2.44M). INMB YTD gains are higher at: 63.383 vs. WINT (-96.191). WINT has higher annual earnings (EBITDA): -9.36M vs. INMB (-41.52M). INMB has more cash in the bank: 19.3M vs. WINT (917K). INMB has less debt than WINT: INMB (347K) vs WINT (2.01M). INMB has higher revenues than WINT: INMB (50K) vs WINT (0).
INMBWINTINMB / WINT
Capitalization177M2.44M7,269%
EBITDA-41.52M-9.36M444%
Gain YTD63.383-96.191-66%
P/E RatioN/A0.83-
Revenue50K0-
Total Cash19.3M917K2,105%
Total Debt347K2.01M17%
FUNDAMENTALS RATINGS
INMB vs WINT: Fundamental Ratings
INMB
WINT
OUTLOOK RATING
1..100
757
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
57
Fair valued
PROFIT vs RISK RATING
1..100
86100
SMR RATING
1..100
9697
PRICE GROWTH RATING
1..100
5697
P/E GROWTH RATING
1..100
1005
SEASONALITY SCORE
1..100
8555

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

WINT's Valuation (57) in the Biotechnology industry is somewhat better than the same rating for INMB (92). This means that WINT’s stock grew somewhat faster than INMB’s over the last 12 months.

INMB's Profit vs Risk Rating (86) in the Biotechnology industry is in the same range as WINT (100). This means that INMB’s stock grew similarly to WINT’s over the last 12 months.

INMB's SMR Rating (96) in the Biotechnology industry is in the same range as WINT (97). This means that INMB’s stock grew similarly to WINT’s over the last 12 months.

INMB's Price Growth Rating (56) in the Biotechnology industry is somewhat better than the same rating for WINT (97). This means that INMB’s stock grew somewhat faster than WINT’s over the last 12 months.

WINT's P/E Growth Rating (5) in the Biotechnology industry is significantly better than the same rating for INMB (100). This means that WINT’s stock grew significantly faster than INMB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INMBWINT
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
80%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
79%
Momentum
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
88%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 8 days ago
76%
Declines
ODDS (%)
Bearish Trend 15 days ago
88%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
85%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
INMB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WINT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
THOIX41.810.29
+0.70%
Thornburg Global Opportunities I
CGEOX18.660.05
+0.27%
Calamos Global Equity R6
JPDVX16.05N/A
N/A
JPMorgan Diversified L
FLIAX10.37N/A
N/A
First Sentier American Listed Infras Ins
HQIRX20.69N/A
N/A
Hartford Equity Income R3

INMB and

Correlation & Price change

A.I.dvisor indicates that over the last year, INMB has been loosely correlated with ABCL. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if INMB jumps, then ABCL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INMB
1D Price
Change %
INMB100%
+4.95%
ABCL - INMB
47%
Loosely correlated
+4.76%
PRME - INMB
43%
Loosely correlated
-0.75%
CRSP - INMB
42%
Loosely correlated
+0.03%
BEAM - INMB
42%
Loosely correlated
+1.60%
EYPT - INMB
41%
Loosely correlated
+0.99%
More

WINT and

Correlation & Price change

A.I.dvisor indicates that over the last year, WINT has been loosely correlated with MLEC. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if WINT jumps, then MLEC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WINT
1D Price
Change %
WINT100%
-15.80%
MLEC - WINT
49%
Loosely correlated
-10.43%
DVHGF - WINT
37%
Loosely correlated
N/A
INMB - WINT
31%
Poorly correlated
+4.95%
DYN - WINT
29%
Poorly correlated
+1.06%
CDTX - WINT
27%
Poorly correlated
+3.22%
More